Skip to main content

Epkinly Disease Interactions

There are 2 disease interactions with Epkinly (epcoritamab).

Moderate

Epcoritamab (applies to Epkinly) active infection

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Infection - Bacterial/Fungal/Protozoal/Viral

Epcoritamab can cause serious and fatal infections. Patients should be evaluated for active infection prior to epcoritamab treatment and administration should be avoided if infection is detected. Consider initiating prophylaxis against herpes virus and pneumocystis jiroveci fungus prior to starting treatment to prevent herpes zoster reactivation and pneumocystis jiroveci pneumonia infection.

References

  1. (2023) "Product Information. Epkinly (epcoritamab)." Genmab US, Inc.
Moderate

Epcoritamab (applies to Epkinly) impaired cognition/consciousness

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Altered Consciousness

Epcoritamab can cause serious adverse reactions that may lead to impaired cognition or consciousness. Patients at increased risk should be evaluated and advised to refrain from operating potentially dangerous machinery until resolution.

References

  1. (2023) "Product Information. Epkinly (epcoritamab)." Genmab US, Inc.

Epkinly drug interactions

There are 234 drug interactions with Epkinly (epcoritamab).


Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.